Interviews

Ricardo Lencioni, MD, shares results from the phase 3 EMERALD-1 study which found the addition of durvalumab and bevacizumab to TACE improved progression-free survival among patients with hepatocellular carcinoma, compared with TACE alone.

In this brief interview, Oleksandra Kutsenko, MD at Red Rock Radiology Associates, shares how she successfully manages Y90 to the GI tract.

In this interview feature, Dr. Edward Kim discusses HCC highlights, flow-diversion techniques, and running an outpatient IO lab.

In this interview, Dr. AJ Gunn shares insights and lessons about his profession and passions.

Dr. Ripal Gandhi, MD, FSVM, discusses locoregional therapies for the treatment of HCC as well as high lung shunt management for HCC patients.

Dr. Maxine Tran and Dr. David Breen discuss the partnership of interventional radiology and urology in the treatment of RCC. Some of the topics of specific interest are the collaboration between urologists and interventional radiologists,...

The interventional oncology field is one that is ever-expanding and bringing fresh perspectives and innovative solutions for cancer care to the forefront of the health industry. IO Learning recently interviewed  Mohammad Elsayed, MD,...

IO Learning spoke with Jeff Elton, President and CEO of ConcertAI, and Dan McSweeney, President of TeraRecon, the healthcare business unit of ConcertAI, to discuss how ConcertAI can help both IO professionals and their patients now and in the...

Dr Kamel, interventional radiology section chief, was looking for a partner to help create his vision for the future, focused on growing the interventional oncology practice. In order to support this growth, he needed a partner who shared...